Endimension has raised $311K in its seed round drove by Inflection Point Ventures (IPV)
Endimension, an AI healthcare startup, has raised Rs 2.3 crore or $311K in its seed round drove by Inflection Point Ventures (IPV). According to the Mumbai-based startup, the new capital will be utilized to acquire talent for new item advancement, R&D and for boosting the sales team to ramp up f
Endimension, an AI healthcare startup, has raised Rs 2.3 crore or $311K in its seed round drove by Inflection Point Ventures (IPV).
According to the Mumbai-based startup, the new capital will be utilized to acquire talent for new item advancement, R&D and for boosting the sales team to ramp up further development.
Established by Bharadwaj Sai Komaravolu, Kurien Zacharia and Apparao M L V, Endimension creates AI answers for medical image analysis. It serves to automatically identify abnormalities and diseases, via AI algorithms from medical scans, in order to diminish patient misdiagnosis and increase Radiologists’ proficiency.
The startup claims that it is right now being utilized across 100 hospitals and radiology labs in India. Endimension stands solid with a commendable in-house AI innovation team and a combined encounter of more than 35 years.
Last week, Inflection Point Ventures (IPV) had backed a Home interiors startup Shadez in its $200K pre-Series A round.
Reader questions.
About “Endimension has raised $311K in its seed round drove by Inflection Point Ventures (IPV)” — five of the most-asked, in the desk's own words.
01What is this story about?
Endimension, an AI healthcare startup, has raised Rs 2.3 crore or $311K in its seed round drove by Inflection Point Ventures (IPV). According to the Mumbai-based startup, the new capital will be utilized to acquire talent for new item advancement, R&D and for boosting the sales team to ramp up f02Who wrote it?
Sheena · Staff. 1 min read · Sep 26, 2021.03Is this sponsored?
If a piece is, the disclosure sits above the cover image and again in our public transparency report. This one carries no commercial disclosure.04How do I get the rest?
Subscribe to The Briefing for a Wednesday letter from the desk, or browse by category from the top navigation.
